Preferred Label : Severe Adverse Event;

NCIt synonyms : Grade 3 Severe Adverse Event; Standard Toxicity Grade 3;

NCIt related terms : SEVERE; Grade 3; CTCAE Grade 3; 3; Common Terminology Criteria for Adverse Events Grade 3; Toxicity Value 3;

NCIt definition : An adverse event experience that requires intensive therapeutic intervention and interrupts usual daily activities.;

Alternative definition : CDISC: A type of adverse event that interrupts usual activities of daily living, or significantly affects clinical status, or may require intensive therapeutic intervention.;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3490837/fr/esbriet-pirfenidone-fibrose-pulmonaire-idiopathique-fpi-severe
2024
false
false
false
France
evaluation of the transparency committee
Borg Category-Ratio 10 Perceived Exertion Score 5
Epidermal cGVHD Score 4
fibrosis of lung, nos
Severe Adverse Event
Pirfenidone
idiopathic pulmonary fibrosis
severe
esbriet
Severe Dysplasia
pirfenidone
unknown (origin)
Severe Hallucination
Idiopathic Pulmonary Fibrosis
Severe Extremity Pain
Intensity and Distress 5
pirfenidone

---
https://www.reseau-naissance.fr/medias/2016/12/Anesthesie-chez-parturiente-obese-severe-PRO_012-RSN.pdf
2024
France
guideline
Delivery of Placenta
morbidity
parturition
Borg Category-Ratio 10 Perceived Exertion Score 5
anesthesia
Severe Hallucination
Water Delivery
lack of sensation
obesity
Severe Dysplasia
FBXW4 wt Allele
Intensity and Distress 5
Delivery
Epidermal cGVHD Score 4
Severe Extremity Pain
Anesthesia Procedure
parturition, nos
Obese
Transfer
Birth
Severe Adverse Event
Benzocaine
severe

---
https://www.has-sante.fr/jcms/p_3473151/fr/dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2023
France
guidelines for drug use
No Treatment for Diabetes
Nucala
Omalizumab
Borg Category-Ratio 10 Perceived Exertion Score 5
Omalizumab
Treat
tezspire
Treatment
Treatment Study
Severe Hallucination
Intensity and Distress 5
Severe Adverse Event
During Treatment
Epidermal cGVHD Score 4
Asthma
Dupilumab
asthma
Fasenra
Asthma Pathway
xolair
severe
Severe Dysplasia
asthma, nos
On Treatment
GDC Treatment Frequency Terminology
Treatment Epoch
Therapy Object
Dupixent
asthma
Biomaterial Treatment
Severe Extremity Pain
Mepolizumab

---
Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.